BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

192 related articles for article (PubMed ID: 31529309)

  • 1. Comprehensive Exploration to Identify Predictive DNA Markers of ΔNp63/SOX2 in Drug Resistance in Human Esophageal Squamous Cell Carcinoma.
    Ooizumi Y; Kojima K; Igarashi K; Tanaka Y; Harada H; Yokota K; Kaida T; Ishii S; Tanaka T; Yokoi K; Nishizawa N; Washio M; Ushiku H; Katoh H; Kosaka Y; Mieno H; Hosoda K; Watanabe M; Katada C; Hiki N; Yamashita K
    Ann Surg Oncol; 2019 Dec; 26(13):4814-4825. PubMed ID: 31529309
    [TBL] [Abstract][Full Text] [Related]  

  • 2. TP63, SOX2, and KLF5 Establish a Core Regulatory Circuitry That Controls Epigenetic and Transcription Patterns in Esophageal Squamous Cell Carcinoma Cell Lines.
    Jiang YY; Jiang Y; Li CQ; Zhang Y; Dakle P; Kaur H; Deng JW; Lin RY; Han L; Xie JJ; Yan Y; Doan N; Zheng Y; Mayakonda A; Hazawa M; Xu L; Li Y; Aswad L; Jeitany M; Kanojia D; Guan XY; Said JW; Yang W; Fullwood MJ; Lin DC; Koeffler HP
    Gastroenterology; 2020 Oct; 159(4):1311-1327.e19. PubMed ID: 32619460
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Elevated expression of ΔNp63 in advanced esophageal squamous cell carcinoma.
    Kumakura Y; Rokudai S; Iijima M; Altan B; Yoshida T; Bao H; Yokobori T; Sakai M; Sohda M; Miyazaki T; Nishiyama M; Kuwano H
    Cancer Sci; 2017 Nov; 108(11):2149-2155. PubMed ID: 28892579
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Long non-coding RNA LINC00337 induces autophagy and chemoresistance to cisplatin in esophageal squamous cell carcinoma cells via upregulation of TPX2 by recruiting E2F4.
    Yang C; Shen S; Zheng X; Ye K; Ge H; Sun Y; Lu Y
    FASEB J; 2020 May; 34(5):6055-6069. PubMed ID: 32239565
    [TBL] [Abstract][Full Text] [Related]  

  • 5. LncRNA-TUSC7/miR-224 affected chemotherapy resistance of esophageal squamous cell carcinoma by competitively regulating DESC1.
    Chang ZW; Jia YX; Zhang WJ; Song LJ; Gao M; Li MJ; Zhao RH; Li J; Zhong YL; Sun QZ; Qin YR
    J Exp Clin Cancer Res; 2018 Mar; 37(1):56. PubMed ID: 29530057
    [TBL] [Abstract][Full Text] [Related]  

  • 6. PRMT1 regulates the tumour-initiating properties of esophageal squamous cell carcinoma through histone H4 arginine methylation coupled with transcriptional activation.
    Zhao Y; Lu Q; Li C; Wang X; Jiang L; Huang L; Wang C; Chen H
    Cell Death Dis; 2019 May; 10(5):359. PubMed ID: 31043582
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Genome-wide copy number variation analysis identified ANO1 as a novel oncogene and prognostic biomarker in esophageal squamous cell cancer.
    Yu Y; Cao J; Wu W; Zhu Q; Tang Y; Zhu C; Dai J; Li Z; Wang J; Xue L; Zhen F; Liu J; Huang C; Zhao F; Zhou Y; Wen W; Pan X; Wei H; Zhu Y; He Y; Que J; Wang W; Luo J; Xu J; Chen L
    Carcinogenesis; 2019 Oct; 40(10):1198-1208. PubMed ID: 31050728
    [TBL] [Abstract][Full Text] [Related]  

  • 8. ΔNp63-restricted viral mimicry response impedes cancer cell viability and remodels tumor microenvironment in esophageal squamous cell carcinoma.
    Yu VZ; So SS; Lung BC; Hou GZ; Wong CW; Chow LK; Chung MK; Wong IY; Wong CL; Chan DK; Chan FS; Law BT; Xu K; Tan ZZ; Lam KO; Lo AW; Lam AK; Kwong DL; Ko JM; Dai W; Law S; Lung ML
    Cancer Lett; 2024 Jul; 595():216999. PubMed ID: 38823762
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The DMRTA1-SOX2 positive feedback loop promotes progression and chemotherapy resistance of esophageal squamous cell carcinoma.
    Zhang R; Zhou P; Ou X; Zhao P; Guo X; Xi M; Qing C
    Oncol Res; 2023; 31(6):887-897. PubMed ID: 37744275
    [TBL] [Abstract][Full Text] [Related]  

  • 10. SOX2/SALL4 stemness axis modulates Notch signaling genes to maintain self-renewal capacity of esophageal squamous cell carcinoma.
    Forghanifard MM; Kasebi P; Abbaszadegan MR
    Mol Cell Biochem; 2021 Feb; 476(2):921-929. PubMed ID: 33098486
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Sox2 induces tumorigenesis and angiogenesis of early-stage esophageal squamous cell carcinoma through secretion of Suprabasin.
    Takahashi K; Asano N; Imatani A; Kondo Y; Saito M; Takeuchi A; Jin X; Saito M; Hatta W; Asanuma K; Uno K; Koike T; Masamune A
    Carcinogenesis; 2020 Nov; 41(11):1543-1552. PubMed ID: 32055838
    [TBL] [Abstract][Full Text] [Related]  

  • 12. SOX2 identified as a target gene for the amplification at 3q26 that is frequently detected in esophageal squamous cell carcinoma.
    Gen Y; Yasui K; Zen Y; Zen K; Dohi O; Endo M; Tsuji K; Wakabayashi N; Itoh Y; Naito Y; Taniwaki M; Nakanuma Y; Okanoue T; Yoshikawa T
    Cancer Genet Cytogenet; 2010 Oct; 202(2):82-93. PubMed ID: 20875870
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Effects and mechanisms of FBXO31 on Taxol chemoresistance in esophageal squamous cell carcinoma.
    Lv L; Wang SC; Mo JY; Huang KL; Xu ML; Liu J
    Biochem Biophys Res Commun; 2022 Jan; 586():129-136. PubMed ID: 34839191
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Bromodomain protein BRDT directs ΔNp63 function and super-enhancer activity in a subset of esophageal squamous cell carcinomas.
    Wang X; Kutschat AP; Yamada M; Prokakis E; Böttcher P; Tanaka K; Doki Y; Hamdan FH; Johnsen SA
    Cell Death Differ; 2021 Jul; 28(7):2207-2220. PubMed ID: 33658703
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Glutathione S-transferase Pi 1 is a valuable predictor for cancer drug resistance in esophageal squamous cell carcinoma.
    Ogino S; Konishi H; Ichikawa D; Matsubara D; Shoda K; Arita T; Kosuga T; Komatsu S; Shiozaki A; Okamoto K; Kishimoto M; Otsuji E
    Cancer Sci; 2019 Feb; 110(2):795-804. PubMed ID: 30499150
    [TBL] [Abstract][Full Text] [Related]  

  • 16. SOX2 antagonizes WWC1 to drive YAP1 activation in esophageal squamous cell carcinoma.
    Chai Y; Li Q; Zhao H; Zhang Z; Yu X; Pang L; Liu Z; Zhao J; Wang L; Li F
    Cancer Med; 2019 Nov; 8(16):7055-7064. PubMed ID: 31560173
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Nicotinamide N-methyltransferase decreases 5-fluorouracil sensitivity in human esophageal squamous cell carcinoma through metabolic reprogramming and promoting the Warburg effect.
    Cui Y; Yang D; Wang W; Zhang L; Liu H; Ma S; Guo W; Yao M; Zhang K; Li W; Zhang Y; Guan F
    Mol Carcinog; 2020 Aug; 59(8):940-954. PubMed ID: 32367570
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Aberrant MCM10 SUMOylation induces genomic instability mediated by a genetic variant associated with survival of esophageal squamous cell carcinoma.
    Tian J; Lu Z; Niu S; Zhang S; Ying P; Wang L; Zhang M; Cai Y; Dong T; Zhu Y; Zhong R; Wang Z; Chang J; Miao X
    Clin Transl Med; 2021 Jun; 11(6):e485. PubMed ID: 34185429
    [TBL] [Abstract][Full Text] [Related]  

  • 19. NOTCH3 limits the epithelial-mesenchymal transition and predicts a favorable clinical outcome in esophageal cancer.
    Matsuura N; Tanaka K; Yamasaki M; Yamashita K; Saito T; Makino T; Yamamoto K; Takahashi T; Kurokawa Y; Nakajima K; Eguchi H; Nakagawa H; Doki Y
    Cancer Med; 2021 Jun; 10(12):3986-3996. PubMed ID: 34042293
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Promoter hypermethylation-mediated downregulation of tumor suppressor gene SEMA3B and lncRNA SEMA3B-AS1 correlates with progression and prognosis of esophageal squamous cell carcinoma.
    Dong Z; Liang X; Wu X; Kang X; Guo Y; Shen S; Liang J; Guo W
    Clin Exp Metastasis; 2019 Jun; 36(3):225-241. PubMed ID: 30915595
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.